Related references
Note: Only part of the references are listed.Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases
Caleb F. Anderson et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics
Bhuvaneshwar Vaidya et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment
Vineela Parvathaneni et al.
PHARMACEUTICS (2020)
The solid progress of nanomedicine
Joao Pedro Martins et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Preparation and Characterization of Itraconazole- or Miconazole-Loaded PLGA Microspheres
Kazuhiro Matsuura et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
J. Gao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer
Bhuvaneshwar Vaidya et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses
Remi Rosiere et al.
CANCERS (2019)
Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids
Aleksandra Tchoryk et al.
BIOCONJUGATE CHEMISTRY (2019)
Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment
Nishant S. Kulkarni et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis
Haitao Yang et al.
PHARMACEUTICS (2019)
Poly(lactic-co-glycolic acid) Nanoparticles Loaded with Callistemon citrinus Phenolics Exhibited Anticancer Properties against Three Breast Cancer Cell Lines
Rashid Ahmed et al.
JOURNAL OF FOOD QUALITY (2019)
Preparation, Optimization, and In Vivo Evaluation of Nanoparticle-Based Formulation for Pulmonary Delivery of Anticancer Drug
Nazimuddin Chishti et al.
MEDICINA-LITHUANIA (2019)
On the issue of transparency and reproducibility in nanomedicine
Hon S. Leong et al.
NATURE NANOTECHNOLOGY (2019)
Development and Evaluation of Paclitaxel-Loaded Aerosol Nanocomposite Microparticles and Their Efficacy Against Air-Grown Lung Cancer Tumor Spheroids
Elisa A. Torrico Guzman et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
Snehal K. Shukla et al.
PHARMACEUTICS (2019)
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
Fatemeh Farjadian et al.
NANOMEDICINE (2019)
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
Cecilia Velino et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Akhand Pratap Singh et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Study on influence of polymer and surfactant on in vitro performance of biodegradable aqueous-core nanocapsules of tenofovirdisoproxil fumarate by response surface methodology
Grandhi Srikar et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Jens Markus Borghardt et al.
CANADIAN RESPIRATORY JOURNAL (2018)
Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics
Ali Dabbagh et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2018)
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
Hadeer M. Abdelaziz et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Afatinib restrains K-RAS-driven lung tumorigenesis
Herwig P. Moll et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
Parisa Foroozandeh et al.
NANOSCALE RESEARCH LETTERS (2018)
Afatinib Therapy Practical management of adverse events with an oral agent for non-small cell lung cancer treatment
Rebecca L. Edwards et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development
Yeonho Jo et al.
THERANOSTICS (2018)
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Fakhar Ud Din et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis
Jing Tang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer
Susanne R. Youngren-Ortiz et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2017)
Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
Andrew S. Gdowski et al.
NANOMEDICINE (2017)
Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines
Gianpiero Lazzari et al.
POLYMER CHEMISTRY (2017)
Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells
Chun Xie et al.
FRONTIERS IN PHARMACOLOGY (2017)
Cellular uptake of nanoparticles: journey inside the cell
Shahed Behzadi et al.
CHEMICAL SOCIETY REVIEWS (2017)
Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
Sharad Mangal et al.
ACTA PHARMACOLOGICA SINICA (2017)
Comparison of Tumor Penetration of Podophyllotoxin-Carboxymethylcellulose Conjugates with Various Chemical Compositions in Tumor Spheroid Culture and In Vivo Solid Tumor
Yang Yang et al.
BIOCONJUGATE CHEMISTRY (2017)
Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response
Bianca Galateanu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Enzyme-responsive multistage vector for drug delivery to tumor tissue
Yu Mi et al.
PHARMACOLOGICAL RESEARCH (2016)
Engineering nanoparticles to overcome barriers to immunotherapy
Randall Toy et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2016)
Nanoparticles in the clinic
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2016)
In Vitro Tumor Models: Advantages, Disadvantages, variables, and Selecting the Right Platform
Moriah E. Katt et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2016)
Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy
M. Moreno-Sastre et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer
Seong Ho Choi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanotechnology approaches for inhalation treatment of lung diseases
Andriy Kuzmov et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation
Shirong Zhang et al.
ONCOTARGET (2015)
Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer
Yajun Guo et al.
ONCOLOGY LETTERS (2015)
Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Deepa Subramaniam et al.
CURRENT CANCER DRUG TARGETS (2014)
The effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophages
Karin H. Mueller et al.
BIOMATERIALS (2014)
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
Yi-Long Wu et al.
LANCET ONCOLOGY (2014)
Three-dimensional cell culture: the missing link in drug discovery
Susan Breslin et al.
DRUG DISCOVERY TODAY (2013)
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
Vivek Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Spheroid culture as a tool for creating 3D complex tissues
Eelco Fennema et al.
TRENDS IN BIOTECHNOLOGY (2013)
Epidemiology of Lung Cancer
Carole A. Ridge et al.
SEMINARS IN INTERVENTIONAL RADIOLOGY (2013)
Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers
Peter Stopfer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
Flavio Solca et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro
Ying-Zheng Zhao et al.
CANCER LETTERS (2011)
Influence of particle size on regional lung deposition - What evidence is there?
Thiago C. Carvalho et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: Effect of formulation variables
Aman Soni et al.
ASIAN JOURNAL OF PHARMACEUTICS (2011)
Matrix Metalloproteinase-9 Is Increased in Obese Subjects and Decreases in Response to Pioglitazone
Resat Unal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Formulation Optimization of Etoposide Loaded PLGA Nanoparticles by Double Factorial Design and their Evaluation
Khushwant Yadav et al.
Current Drug Delivery (2010)
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
Malgorzata S. Cartiera et al.
BIOMATERIALS (2009)
Improved cellular uptake of chitosan-modi fled PLGA nanospheres by A549 cells
Kohei Tahara et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification
G. Gasparini et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2008)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
W Pao et al.
PLOS MEDICINE (2005)
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating
C Wilhelm et al.
BIOMATERIALS (2003)
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
NR Labiris et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
HY Kwon et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2001)
Share Paper
